Remepy Employee Directory
Biotechnology ResearchNew York, United States51-200 Employees
Remepy is a biotechnology research company based in New York City that develops Hybrid Drugs—therapies that combine traditional pharmaceuticals with digitally guided treatment protocols. At the core of its platform are Digital Molecules, software-like components embedded in the drug that deliver digital interventions tailored to each medical condition and its corresponding medication. These digital elements are continuously measured and personalized using artificial intelligence to optimize drug performance while addressing physical, motor, psychological, and behavioral symptoms, and to support neuro-endocrine and neuro-immunological balance and neuroplasticity. \n\nRemepy pursues collaborations with pharmaceutical companies to bring Hybrid Drugs to market. In 2026 it announced a collaboration with Merck KGaA to develop single-prescription Hybrid Drugs that pair conventional medicines with AI-driven digital therapies across multiple disease areas.
1-888-653-2347 
support@leadiq.com 
